Candriam is a global asset management company with a 25-year track record in ESG Investing. #Investing4Tomorrow

Europe
Joined May 2011
⚡ 120 GW of mature renewable projects could be at risk of not securing timely grid access by 2030. For investors, the potential extends across the energy value chain, but it will not be evenly distributed. So which capabilities will set companies apart? candriam.com/en/professional…
72
S&P 500 up ~12% through September, US Treasuries down ~3%. Can Q3 earnings clear a higher bar? Explore our full market views 👇 Allocation: candriam.com/en/professional… Equities: candriam.com/en/professional… Fixed Income: candriam.com/en/professional… Alternatives: candriam.com/en/professional…
1
84
Question for the investment advisors: where does #creditInvesting fit in your clients’ portfolios? Credit is a broad toolkit, suiting the various needs: ☑️ Diversification ☑️ Income potential ☑️ Sustainability goals Discocer more about it 👉 candriam.com/en/professional…
1
88
#PinkOctober 20 million new cancer cases diagnosed each year. Yet the 5-year survival rate crossed 70% in 2025. For investors, the question is not whether oncology is advancing. It is which companies will turn that progress into long-term opportunities👉 candriam.com/en/professional…
106
If you are an #institutionalInvestor, chances are geopolitical and fiscal uncertainty is testing your asset allocation assumptions. And #corporateBonds probably now sit at the centre of the debate within your organisation. Our next webinar about it 👉 event.eu.on24.com/wcc/r/8000…
1
127
$2.2 trillion already invested in climate mitigation . $65 billion in adaptation investments, a fraction of what is needed. So why not redirect all climate investment toward adaptation instead? Discover why that reasoning misses the point. Full replay👉 event.eu.on24.com/wcc/r/8000…
112
30 to 40% of people who develop cancer could have been identified in the years before their diagnosis. For #PinkOctober, our Institute is highlighting a programme launched by the cancer centre @GustaveRoussy to act within that window of opportunity 👉 institute.candriam.com/news2…
1
94
$750bn. That's what hyperscaler capital expenditure could reach in 2026, with debt expected to finance roughly 1/3 of it. The #AI boom is now a bond market story. Question: who ultimately carries the risk? Explore the topic, download our white paper 👉 candriam.com/en/professional…
93
In our latest ESG Talks webinar, we explored: · Why climate change is no longer a distant investment risk · Why investors need to look beyond portfolio decarbonisation · Where opportunities may emerge across the transition Replay 👉 event.eu.on24.com/wcc/r/8000…
1
107
Zero issuer defaults* in #CreditInvesting. That's not a coincidence. It's the result of discipline. The point lies in taking risk deliberately: understanding it well enough to price it, size it, and decide when it's worth owning👉 candriam.com/en/professional… *Over a 25-year period
141
#CreditInvesting is built on risk. And that risk is where the opportunity lies 💡 But taming it is crucial. Explore our 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀 𝗼𝗻 𝗰𝗿𝗲𝗱𝗶𝘁 𝗶𝗻𝘃𝗲𝘀𝘁𝗶𝗻𝗴 👉candriam.com/en/professional…
147
Climate financial risks, asset allocation, portfolio resilience: where do they meet? Next week, our webinar "Too hot to ignore: Investing in a warming world" will explore the topic. Last chance to register 👉 event.eu.on24.com/wcc/r/8000…
153
💡Credit risk is never one variable. It's a system: Issuer fundamentals, rates, liquidity, all interacting and depending on the phase of the cycle. Also, the same issuer can be traded under very different conditions. Our approach to #creditInvesting 👉 candriam.com/en/professional…
1
139
📊 Are markets already pricing in financial climate risk? In our next webinar, we will explore: • Where these risks are material for investors. • Where the long-term investment potential lies. Register 👉 event.eu.on24.com/wcc/r/8000…
159
🧬 Could healthcare be the next market leader? #Biotech has already been a strong performer over the past year, and the picture may extend beyond biopharma, into medtech and life science tools. What does this mean for investors looking beyond big tech?👉 event.eu.on24.com/wcc/r/8000…
142
Leadership fit is a moving target. And the board's job is not simply to appoint the right CEO today. It is to ensure the company has the right leadership for the phase ahead 👉 candriam.com/en/professional…
139
Bonds are becoming #bonds again. As part of our latest webinar, our #FixedIncome expert shares his views on rates and credit. 📊Where can bond investors still find opportunity, and where should they remain cautious? Full replay of this webinar 👉 event.eu.on24.com/wcc/r/8000…
146
Our latest market views: AssetAllocation 👉 candriam.com/en/professional… Equities 👉 candriam.com/en/professional… FixedIncome 👉 candriam.com/en/professional… AlternativeStrategies 👉 candriam.com/en/professional…
1
146
#Robotics is no longer one market, it is several, all accelerating at once. Four structural forces are converging, turning robotics from a niche industrial application into a broad-based investment theme. Explore this #megatrend 👉 candriam.com/en-fr/professio…
1
153
Through the #CandriamInstituteForSustainableDevelopment, we support @natagora and @MijnNatuurpunt in helping landscapes retain water, protect stored carbon and support biodiversity. Very tangible project, with true impact 🌍 Discover the project 👉 institute.candriam.com/news2…
154